Third largest global contract research, development and manufacturing organization (CRDMO) that provides biopharmaceutical partners with fully integrated services to support drug discovery, development and manufacturing for both drug substance and drug product.
- 2005 Year invested
Global contract development and manufacturing organization (CDMO) focused on Sterile Injectables, spanning development to full scale commercial production across Oncology/High Potency, Blow-Fill-Seal and multi format vial streams.
Global clinical-stage biotechnology company utilizing proprietary Conditionally Active Biologics (CAB) technology to develop novel monoclonal antibody and other protein therapeutic product candidates with more selective targeting, greater efficacy, and more cost-efficient and predictable manufacturing than traditional antibodies.
An award winning global technology services firm and proud Microsoft Partner with Gold Status across numerous competencies. Provoke helps its clients flourish by delivering impactful software that delights users. Provoke believes clients deserve better than competitive services that are late, over-engineered, and over budget with outputs that miss the point.
A fabless semiconductor company providing state of the art, disruptive chipset solutions in Power Management and Smart Audio across a wide spectrum of applications from Mobile devices, IoT, Personal Computers, and Cloud Servers.
- 2019 Year invested
Clinical stage, therapeutic company developing innovative, differentiated CAB antibody therapies in greater China. Himalaya Therapeutics strives to deliver safer, more potent cancer therapies timely and cost effectively to patients.
- 2020 Year invested
- Carolyn Short, CEO
The power of location intelligence is at work, enabling businesses to create frictionless experiences. Macro- and micro-location solutions turn physical-world data into action for operators, marketers, and analysts looking to improve their omnichannel strategies.
- 2014 Year invested
- Rob Emrich, CEO
Preclinical biopharmaceutical development company focusing on best-in-class small and large molecule therapeutics, and cell-therapy, to address the unmet medical needs of patients.
- 2015 Year invested
A Bridgewest Ventures New Zealand Incubator company that delivers a test automation platform, SaaS, and ERP automated testing and release management, leveraging AI to lower costs and de-risk software upgrade acceptance.
- 2021 Year invested
Pioneering advancements in Artificial Intelligence leverage expert data science for AI algorithms and IOT smart devices from edge to cloud, that garner meaningful sensory data insights and establish critical building blocks for ethical AI.
A software development company that develops, maintains, and enhances software solutions to help companies build digital products and scale teams. Modernization and optimization of business software solutions through dedicated teams enable companies to focus on the core aspects of running their business.
A biotechnology company that leverages patented 3D printed chromatography columns for separating and purifying biological molecules from a fluid mixture. The crucial technology serves the medicinal therapeutics industry, enabling purification of DNA, RNA, viruses, and antibodies that are used in vaccines and cell and gene therapies.
Highly engineered, specification grade commercial lighting solutions designed with application centric approach and compatibility for a broad range of controls.
- 2017 Year invested
Real estate company with a broad global portfolio spanning speciality commerical sites, business centers, residential and mixed-used buildings.
- 2009 Year invested